The psychedelic state is unquestionably one of the most interesting psychological experiences humans can have. Hallucinogenic drugs that have been used by humans for as long as we can determine to provide novel insights into the mind and enhance social bonding. For...
This question can be approached from a number of different levels. At the lowest functionally relevant level, how do the hallucinogenic compounds themselves interact with a certain neurotransmitter receptor to alter neuronal activity? Then at the neuronal population...
The first results from Phase 3 trials testing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) have been announced. The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving the way for a...
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
The latest research into psilocybin therapy as a treatment for tobacco addiction has yielded promising results. Johns Hopkins Medicine was awarded a US$4-million grant by the National Institutes of Health (NIH) to further clinical research investigating...
As recent trials of psychedelic-assisted psychotherapy enter the last phase of testing, the coming need for psychedelic training seems inevitable. The demand for many trained therapists and guides will be high. Until recently, the lone opportunity to train and work...
